Therapeutic interventions targeted to block kinase activity of ErbB2 may have the potential to prevent nerve degeneration in leprosy and other demyelinating diseases at an early stage before the progression of these neurodegenerative diseases. The gene discussed is ERBB2; the disease is demyelinating disease.